Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Alnylam Pharmace. buy Piper Sandler

Alnylam Pharmace.
Start price
€169.60
14.12.23 / 50%
Target price
€197.08
14.12.24
Performance (%)
36.79%
End price
€232.00
15.12.24
Summary
This prediction ended on 15.12.24 with a price of €232.00. With a performance of 36.79% the BUY prediction by Piper_Sandler was a big success. Piper_Sandler has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Piper_Sandler has 50% into this prediction

Alnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.

Performance without dividends (%)
Name 1w 1m 1y
Alnylam Pharmace. 2.079% 2.079% 9.960%
iShares Core DAX® -0,48 % -12,06 % -2,95 %
iShares Nasdaq 100 -3,38 % -5,13 % 9,58 %
iShares Nikkei 225® -0,14 % -12,63 % 20,32 %
iShares S&P 500 -2,27 % -5,05 % 5,80 %

Comments by Piper_Sandler for this prediction

In the thread Alnylam Pharmace. diskutieren
Prediction Buy
Perf. (%) 36.79%
Target price 197.079
Change
Ends at 14.12.24

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Piper Sandler from $210.00 to $217.00. They now have an "overweight" rating on the stock.
Ratings data for ALNY provided by MarketBeat

Piper Sandler 
0
Report Share
14.12.23
In the thread Trading Alnylam Pharmace.
Prediction Buy
Perf. (%) 36.79%
Target price 197.079
Change
Ends at 14.12.24

Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten

Piper Sandler 
0
Report Share
15.12.24

Current prediction by Piper_Sandler for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€395.60
31.10.25
€422.59
31.10.26
-30.51%
27.03.26

Piper Sandler 
31.10.25 50%

Stopped prediction by Piper_Sandler for Alnylam Pharmace.

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€219.20
18.11.24
€279.36
18.11.25
80.66%
19.11.25

Piper Sandler 
18.11.24 50%